$VOR

$18.33 +$0.07 (0.38%) Close

$VOR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 59.2M shares outstanding

Who owns VOR?

By type of holder

Institutions 82.0% Insiders 8.5% Everyone else 9.6%

Concentration Top 10 holders own 126.8%

Peter Kolchinsky 21.9% · Rajeev Shah 21.9%

Institutional ownership

82.0%

+13.6 pts vs last qtr

Institutional holders

101

+21 vs last qtr

Net shares bought

+8.0M

by institutions in Q2 2026

New / sold out

39 / 18

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

FMR LLC +3.4M
BlackRock, Inc. +2.7M

Biggest sellers in Q2 2026

Ra Capital Management, L.P. −3.0M
Marshall Wace, LLP −1.1M

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Vor Biopharma Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+187.3%

+187.35% a year

Each share's claim on the business

−65.2%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $28.8M

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years36% 3–5 years1% 1–3 years1% Under 1 year62%

Quarterly turnover

24.9%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting VOR on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
TC TCG Crossover Management, LLC	5.7M	9.59%	Unchanged	Q1 '26	2.5%
Shares held by quarter Peak holding5.7M (Q1'26) Change over 8 quarters+5.7M Share of the company9.590% TCG Crossover Management, LLC's full portfolio →
RC Ra Capital Management, L.P. 13D · 19.9%	2.4M	4.06%	−3.0M (−55.6%)	≤2021	0.4%
Shares held by quarter Peak holding39.6M (Q4'24) Change over 8 quarters−20.3M Share of the company4.060% Disclosed stake13D · 19.9% Ra Capital Management, L.P.'s full portfolio →

TCG Crossover Management, LLC

5.7M

% of company

9.59%

Change vs last qtr

Unchanged

Held since

Q1 '26

Ra Capital Management, L.P.

13D · 19.9%

2.4M

% of company

4.06%

Change vs last qtr

−3.0M (−55.6%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Vor Biopharma Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting VOR on Form N-PORT; together they hold 22.6% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SS State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR Series Trust	$32.3M	1.8M	2.97%	0.30%	June 30, 2026
SB Select Biotechnology Portfolio Fidelity Select Portfolios	$31.5M	1.4M	2.37%	0.50%	August 31, 2026

State Street(R) SPDR(R) S&P(R) Biotech ETF

SPDR Series Trust

Position value

$32.3M

% of company

2.97%

% of the fund

0.30%

As of

June 30, 2026

Select Biotechnology Portfolio

Fidelity Select Portfolios

Position value

$31.5M

% of company

2.37%

% of the fund

0.50%

As of

August 31, 2026

23 more funds behind a free account

See every fund holding Vor Biopharma Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
PK Peter Kolchinsky 5%+ holder 13D · 19.9%	12.9M	21.87%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company21.870% Disclosed stake13D · 19.9% View the 13D/G filing →
RS Rajeev Shah 5%+ holder 13D · 19.9%	12.9M	21.87%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company21.870% Disclosed stake13D · 19.9% View the 13D/G filing →

Peter Kolchinsky

5%+ holder13D · 19.9%

12.9M

% of company

21.87%

Change vs last qtr

—

Held since

—

Rajeev Shah

5%+ holder13D · 19.9%

12.9M

% of company

21.87%

Change vs last qtr

—

Held since

—

17 more holders behind a free account

See every insider and 5%+ holder of Vor Biopharma Inc..

Comments